Literature DB >> 8445241

The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization.

E C Hagen1, K Andrassy, E Chernok, M R Daha, G Gaskin, W Gross, P Lesavre, J Lüdemann, C D Pusey, N Rasmussen.   

Abstract

This study describes the results of phase I of an international effort to develop and standardize assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). 12 sera, four of which were selected for their potential to cause problems in the detection of various ANCA specificities, were analyzed in the standard indirect immunofluorescence (IIF) test and in ELISAs for ANCA routinely performed in the seven participating laboratories. The IIF methodology differed with respect to the dilution of the serum being screened and the concentration of the conjugate used. Results from sera with high ANCA titers were similar, although the quantitative values could not be compared. In sera containing rheumatoid factor and anti-nuclear antibodies (ANA), ANCA-unrelated staining patterns were observed. Six antigen preparations were used in ELISA for the detection of cANCA. In ELISA with purified proteinase-3 all three cANCA sera were positive, but not anti-myeloperoxidase (MPO) or anti-lactoferrin (LF) positive sera. The other assays were less sensitive or gave inconsistent results. Various preparations of purified MPO and LF used in ELISA were readily recognized by anti-MPO and anti-LF positive sera. From this study it can be concluded that the IIF test, although performed with different methods, shows comparable results using strongly positive sera. In general solid phase assays for cANCA detection are not well standardized and need improvement although the purified proteinase-3 ELISA is possibly an exception. MPO and LF can be used in ELISA procedures for the detection of pANCA-related antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445241     DOI: 10.1016/0022-1759(93)90136-u

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  26 in total

1.  Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies.

Authors:  S M Chowdhury; V Broomhead; G P Spickett; R Wilkinson
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

Review 2.  Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.

Authors:  A Wiik
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Pulmonary vasculitis.

Authors:  A Burns
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

4.  Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan.

Authors:  T Fukazawa; T Hamada; S Kikuchi; H Sasaki; K Tashiro; S Maguchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

5.  Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.

Authors:  P Yang
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

6.  Anticytokeratins are a potential source of false-positive indirect immunofluorescence assays for C-ANCA.

Authors:  J Streicher; B Fabian; K Herkner; H Pointner; P M Bayer
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

7.  Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection.

Authors:  O A Cornely; S Hauschild; C Weise; E Csernok; W L Gross; B Salzberger; G Fätkenheuer; V Diehl; M Schrappe
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

Review 8.  European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. European Community Study Group on Clinical Trials in Systemic Vasculitis ECSYSVASTRIAL.

Authors: 
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  Formalin fixation and patterns of antineutrophil cytoplasmic antibodies.

Authors:  G P Spickett; V Broomhead
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

10.  The clinical course of ANCA small-vessel vasculitis on chronic dialysis.

Authors:  Sofia Lionaki; Susan L Hogan; Caroline E Jennette; Yichun Hu; Julie B Hamra; J Charles Jennette; Ronald J Falk; Patrick H Nachman
Journal:  Kidney Int       Date:  2009-06-17       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.